Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67 | 65 | 14 | 11 | 8 |
| TOTAL | $75 | $66 | $15 | $12 | $8 |
| Non-Current Assets | |||||
| Investments And Advances | 14 | 12 | 10 | 12 | 14 |
| TOTAL | $14 | $12 | $10 | $12 | $14 |
| Total Assets | $88 | $78 | $25 | $24 | $22 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 117 | 85 | 20 | 27 | 86 |
| Accounts payable and accrued liabilities | 466 | 456 | 338 | 319 | 284 |
| Accrued Expenses | 150 | 148 | 147 | 124 | 105 |
| TOTAL | $733 | $689 | $574 | $928 | $834 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69 | 69 | N/A | 69 | 69 |
| Other Non-Current Liabilities | 72 | 72 | 75 | 114 | 92 |
| TOTAL | $141 | $141 | $75 | $182 | $161 |
| Total Liabilities | $874 | $830 | $649 | $1,110 | $995 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,584 | 52,084 | 46,084 | 41,084 | 41,084 |
| Common Shares | 55 | 52 | 46 | 41 | 39 |
| Retained earnings | -5,687 | -5,647 | -5,182 | -4,198 | -4,015 |
| Other shareholders' equity | 3 | 1 | -1 | 1 | 3 |
| TOTAL | $-786 | $-752 | $-624 | $-1,087 | $-973 |
| Total Liabilities And Equity | $88 | $78 | $25 | $24 | $22 |